• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
TheraCryf
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

TheraCryf “delighted” with cash position after promising first half

mel | 31 October 2023
Categories: Videos

Post navigation

← Investor Meet Company Presentation: Results and AGM
Investor Meet Presentation – Proposed Acquisition of Chronos Therapeutics Ltd, Placing and Accompanying Retail Offer →
  • Privacy Policy
  • Data Protection Complaints Handling Process
  • Sitemap
Get in touch
LinkedIn

© 2026 TheraCryf. ICO Reg: ZB396415. Company Number: 09246681.